Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Apterous Inhibitors

Apterous inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the Apterous protein, a transcription factor that plays a crucial role in developmental processes, particularly in the regulation of gene expression patterns that determine cell fate and identity. Apterous, known primarily from studies in *Drosophila melanogaster* (fruit flies), is a LIM-homeodomain protein, which means it contains both LIM domains that mediate protein-protein interactions and a homeodomain responsible for binding to DNA. Apterous is critically involved in the development of wings and other appendages in flies, and it has homologs in other species that are involved in similar developmental processes. Inhibitors of Apterous function by binding to specific regions of the protein, such as the DNA-binding homeodomain or the LIM domains, thereby preventing it from interacting with DNA or other proteins necessary for its regulatory functions. By inhibiting Apterous, these compounds can disrupt the normal expression of target genes that are critical for the proper development and differentiation of cells. This inhibition can lead to significant downstream effects, including the misregulation of genes involved in the formation of body structures, tissue patterning, and organogenesis. Additionally, Apterous inhibitors may affect the broader network of transcription factors and signaling pathways that interact with Apterous, potentially altering the developmental program of the organism. Understanding the effects of Apterous inhibition provides valuable insights into the role of this transcription factor in developmental biology, shedding light on the complex genetic and molecular mechanisms that govern the formation and differentiation of tissues and organs. This knowledge is essential for exploring how specific transcription factors like Apterous orchestrate the intricate processes of development and the maintenance of cellular identity across different stages of an organism's life cycle.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

This compound binds to DNA at the transcription initiation complex and could prevent the transcription of the apterous gene by RNA polymerase.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

By binding to the eukaryotic ribosome, this compound could halt the translation machinery, leading to a decrease in the production of the apterous protein.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

As a nucleoside analog, this compound could be incorporated into the apterous gene sequence, causing demethylation and potentially downregulating its expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

This compound inhibits histone deacetylase activity, which could lead to hyperacetylation of histones, causing a tight chromatin conformation and reduced access for transcription factors to the apterous gene.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

This compound binds to mTOR, leading to inhibition of the mTOR signaling pathway, which could lead to a reduction in the cellular resources necessary for the expression of the apterous gene.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

As an inhibitor of the MAPK/ERK kinase, this chemical could inhibit the kinase cascade necessary for the expression of certain genes, potentially including the downregulation of the apterous gene.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

This inhibitor targets PI3K, which could lead to a decrease in the phosphorylation of downstream proteins involved in cell survival and growth, potentially leading to reduced expression of the apterous gene.

Spironolactone

52-01-7sc-204294
50 mg
$109.00
3
(1)

This aldosterone antagonist could lead to changes in gene transcription profiles in cells, which may include the downregulation of the apterous gene.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

This benzoquinone ansamycin antibiotic binds to Hsp90, potentially destabilizing its client proteins and thereby possibly leading to a decrease in the stability of transcription factors necessary for apterous gene expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

This toxin found in the Amanita mushroom is a potent inhibitor of RNA polymerase II, which could lead to a potent and direct decrease in the transcription of the apterous gene.